-------- Original Version -----------
Forskare vid Karolinska Institutet har i samarbete med kollegor vid The Scripps Research Institute och Emory University utvecklat en ny vaccinstrategi som lett till antikroppar som kan neutralisera många olika varianter av hiv. Studien, som publiceras i tidskriften Nature, ger ny kunskap om hur immunförsvaret kan styras mot en särskilt svåråtkomlig del av viruset.-------- English Version ------------
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that generates antibodies capable of neutralizing many HIV variants. The study, published in Nature, provides new insights into how the immune system can be directed against a particularly difficult part of the virus.-------- Link if available ----------